About Us


  • 2018

    1. WEINAS series was supported by the "First Breakthrough Fund" of the Shanghai Economic and Information Commission.

    2. WEINAS received CE certificate issued by TUV SUD.

    3. WEIBOND was the first Chinese company to participate in 2018 ASHP Midyear Clinical Meeting & Exhibition more than 60 years.

  • 2017

    WEINAS VD-160 series was officially launched.

  • 2016

    1. WEINAS PD-160 was introduced into Shanghai Jiaotong University Renji Hospital.

    2. WEINAS obtained the "Certificate in Innovation" issued by National Health Commission of China.

    3. WEIBOND stood out among 22,277 companies and won the top 100 Outstanding Enterprises in 5th China Innovation & Entrepreneurship Competition.

  • 2015

    After three years period of test and optimization, WEINAS, the world’s first IV compounding robot which utilizes full-automatic peristatic pump liquid transfer system and is compatible with both vials and ampoules, was officially unveiled.

  • 2014

    We passed ISO 9001 and ISO 13485 quality assurance management system.

  • 2013

    WEINAS prototype was developed successfully and passed the preliminary assessment.

  • 2012

    An unprecedented full-automatic peristatic pump technology was applied to the third generation robot "WEINAS project".

  • 2011

    Due to the intrinsic limitations of syringe-type systems, we decided to change our R&D direction.

  • 2010

    The first generation robot (syringe type) was failed to meet all the design targets, especially the efficiency.

  • 2009

    Weibond was founded by Mr. Liu Baochun.